These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24708748)

  • 1. Clinically relevant characteristics associated with early treatment drug use versus abstinence.
    Cochran G; Stitzer M; Nunes EV; Hu MC; Campbell A
    Addict Sci Clin Pract; 2014 Apr; 9(1):6. PubMed ID: 24708748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Web-based treatment for substance use disorders: differential effects by primary substance.
    Cochran G; Stitzer M; Campbell AN; Hu MC; Vandrey R; Nunes EV
    Addict Behav; 2015 Jun; 45():191-4. PubMed ID: 25697725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Garrett SB; Doyle SR; Floyd AS; Knox PC; Botero C; Kelly TM; Killeen TK; Hayes C; Kau'i Baumhofer N; Seamans C; Zammarelli L
    J Subst Abuse Treat; 2013 Jan; 44(1):103-14. PubMed ID: 22657748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between self-reported mental health status and alcohol and drug abstinence 5 years post-assessment for an addiction disorder in U.S. and Swedish samples.
    Trocchio S; Chassler D; Storbjörk J; Delucchi K; Witbrodt J; Lundgren L
    J Addict Dis; 2013; 32(2):180-93. PubMed ID: 23815425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders.
    Aharonovich E; Campbell ANC; Shulman M; Hu MC; Kyle T; Winhusen T; Nunes EV
    J Addict Med; 2018; 12(2):99-106. PubMed ID: 29194102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR; Lynch KG; Shepard DS; Pettinati HM
    Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.
    Kalapatapu RK; Campbell A; Aharonovich E; Hu MC; Levin FR; Nunes EV
    J Addict Med; 2013; 7(1):66-72. PubMed ID: 23340711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in alcohol and drug use among men seen at a gay-specific substance abuse treatment agency.
    Paul JP; Barrett DC; Crosby GM; Stall RD
    J Stud Alcohol; 1996 Sep; 57(5):475-85. PubMed ID: 8858545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of an outpatient treatment sample by primary substance of abuse.
    Campbell AN; Nunes EV; McClure EA; Hu MC; Turrigiano E; Goldman B; Stabile PQ
    J Addict Med; 2013; 7(5):363-71. PubMed ID: 24089040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence.
    Paraherakis A; Charney DA; Palacios-Boix J; Gill K
    Can J Psychiatry; 2000 Dec; 45(10):927-31. PubMed ID: 11190363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews.
    Smith JW; Frawley PJ
    J Subst Abuse Treat; 1993; 10(4):359-69. PubMed ID: 8105103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.
    McCarty D; Fuller B; Kaskutas LA; Wendt WW; Nunes EV; Miller M; Forman R; Magruder KM; Arfken C; Copersino M; Floyd A; Sindelar J; Edmundson E
    Drug Alcohol Depend; 2008 Jan; 92(1-3):200-7. PubMed ID: 17875368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.
    Reid MS; Jiang H; Fallon B; Sonne S; Rinaldi P; Turrigiano E; Arfken C; Robinson J; Rotrosen J; Nunes EV
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):472-8. PubMed ID: 21854292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.
    Campbell AN; Nunes EV; Miele GM; Matthews A; Polsky D; Ghitza UE; Turrigiano E; Bailey GL; VanVeldhuisen P; Chapdelaine R; Froias A; Stitzer ML; Carroll KM; Winhusen T; Clingerman S; Perez L; McClure E; Goldman B; Crowell AR
    Contemp Clin Trials; 2012 Mar; 33(2):386-95. PubMed ID: 22085803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.